Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

See Remarks

Chief Business Officer

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-08	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-04-04	Premium	acquired	Premium	Premium	Premium	-
2024-04-04	Premium	acquired	Premium	Premium	Premium	-
2024-02-05	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-02-02	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-02-01	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-02-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-01	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-02-01	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-29	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-01-12	Premium	acquired	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	-
2024-01-02	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2023-10-04	Premium	acquired	Premium	Premium	Premium	-
2023-10-04	Premium	acquired	Premium	Premium	Premium	-
2023-10-04	Premium	acquired	Premium	Premium	Premium	-
2023-10-02	Premium	sold	Premium	Premium	Premium	See Remarks
2023-09-20	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-09-07	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2023-09-07	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-09-06	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-09-05	Premium	sold	Premium	Premium	Premium	See Remarks
2023-08-14	Premium	sold	Premium	Premium	Premium	See Remarks

CDNA - CareDx Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for CDNA